Highlights of Ending Age-Related Diseases 2020
Key points from 20 presentations from world-leading researchers
Lewis Gruber
CEO, CSO and Co-Founder of SIWA Therapeutics
He is also the named inventor on all of SIWA Therapeutics’ portfolio of more than 60 global patents.Prior to founding SIWA, Gruber served as interim CEO of ZelleRX, an early stage biotechnology company with a natural killer cell therapy that destroys cancer cells. From 2000 to 2006, Gruber was CEO and Co-Founder of Arryx, Inc., a Chicago biotechnology company that brought to market a breakthrough research tool that uses lasers to allow researchers to simultaneously manipulate hundreds of microscopic objects in three dimensions.
Visit website: https://siwatherapeutics.com/leadership/
See also: 
SIWA Therapeutics
- Biotechnology company producing therapy that targets and destroys senescent cells.
Details last updated 17-Feb-2020
Lewis Gruber Blog Posts
10-Sep-2020
Lewis Gruber News
Super summary of 3rd Annual Longevity Therapeutics Summit
Lifespan.io (LEAF) - 16-Feb-2021
More and more companies making greater and greater progress - 2021 could be an exciting year
Read more...Nature Biotechnology reviews the state of play of senolytics
Nature Biotechnology - 12-Nov-2020
In August, Unity announced that its lead drug candidate had failed to beat a placebo in reducing ...
Read more...LEAF interviews Lewis Gruber about targeting cancer and senescent cells
Lifespan.io (LEAF) - 11-Feb-2020
Biomarker caused by glycolysis seen in all types of cancer - exciting possibilities
Read more...
